When counseling patients with architectural distortion on digital breast tomosynthesis (DBT) but no signs of malignancy on biopsy, mammographers should raise imaging alone as a sound option for surveillance.

In a recent trial, medical students who were trained for two hours or less in an ultrasound “volume sweep” imaging (VSI) protocol obtained diagnostic-quality imaging of palpable breast lesions.

The FDA is notifying patients and referrers of another breast-imaging service’s slide into noncompliance with regulatory standards for image quality.

The FDA is warning patients and referrers about an imaging business near the nation’s capital that has fumbled away its mammography accreditation.

A nonprofit healthcare-certification organization is challenging every user of medical ultrasound in the world to become proficient and certified in the modality by 2030.

COVID-19 set back screening mammography further than any other category of breast care, dropping schedule adherence during infection peaks to 36% of pre-pandemic rates.

Researchers have combined three emerging technologies to detect and classify breast cancers found in follow-up imaging of women whose recent screening mammography was deemed normal.

AI can safely and accurately identify healthy breast tissue on ultrafast breast MRI, negating the need for a radiologist’s closer look and, in the process, lowering cancer screening costs and widening patient access to breast MRI.